The Readout Loud

View Top 200 Chart

Back to Rankings Page

Business
**The Readout Loud**

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Latest Episodes:

Episode 68: A controversial desire drug, courtroom genealogy, & the quest for longer life Jun 20, 2019

Show notes

Is desire a matter of medicine? Can you convict on genealogy? And what do you get the alleged bride who has it all?

Episode 67: Biohacking meets bureaucracy, and the latest twist in CRISPR world Jun 13, 2019

Show notes

Is biohacking a crime? Who came up with the latest CRISPR trick? And did Rage Against the Machine sell out?

Episode 66: The future of cancer treatment, blockbusters interrupted, & an infamous biotech party Jun 06, 2019

Show notes

Who won ASCO? Is pharma sandbagging its blockbusters? And what do gladiators have to do with biotech?

Episode 65: A special episode from the halls of the ASCO meeting Jun 04, 2019

Show notes

What can be done to improve HPV vaccination rates in the U.S.? How does the genetic signature of a tumor lead to an effective cancer drug? What’s it like being a doctor and a cancer patient?

Episode 64: Feuding professors, failing businesses, and journalism 101 May 30, 2019

Show notes

Who's guilty of "clickbait"? Are spit tubes a bad business? And why are academics emulating Pusha T?

Episode 63: Your ASCO preview, genetic whiplash, and a journalist's experience with cancer May 23, 2019

Show notes

What should you watch for at the year's biggest cancer conference? Why are people having 23andMe-induced identity crises? And what's it like to be at once a journalist and a cancer patient?

Episode 62: Drug pricing partisanship, tech's march into health care, and Tinder for clinical trials May 16, 2019

Show notes

Has drug price reform already stalled? How far has tech come in medicine? And should there be an app for that?

Episode 61: Pharma felonies, cardiac CRISPR, and a strange day at the FDA May 09, 2019

Show notes

Are law-breaking pharma executives the new mob bosses? Can genome editing preventing heart attacks? And can the FDA regulate drug prices?

Episode 60: Boardroom drama, whiskey-fueled science, & millionaires on mushrooms May 02, 2019

Show notes

Is Biogen bracing for a fight? What does Jack Daniels have to do with immunotherapy? And will "micro-dosing" light the way to actual therapies?

Episode 59: When scientists get mad online, for-profit cancer care, & the perils of naming a startup Apr 25, 2019

Show notes

Who gets to be "influential"? Should you be skeptical of for-profit hospitals? And should George Lucas fire his attorneys?

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected